NVO logo

Novo Nordisk A/S (NVO) Short term debt

Annual short term debt:

$1.82B+$860.91M(+89.68%)
December 31, 2024

Summary

  • As of today (September 9, 2025), NVO annual short term debt is $1.82 billion, with the most recent change of +$860.91 million (+89.68%) on December 31, 2024.
  • During the last 3 years, NVO annual short term debt has fallen by -$271.43 million (-12.97%).
  • NVO annual short term debt is now -12.97% below its all-time high of $2.09 billion, reached on December 31, 2021.

Performance

NVO Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly short term debt:

$1.88B-$1.36B(-42.00%)
June 1, 2025

Summary

  • As of today (September 9, 2025), NVO quarterly short term debt is $1.88 billion, with the most recent change of -$1.36 billion (-42.00%) on June 1, 2025.
  • Over the past year, NVO quarterly short term debt has increased by +$1.10 billion (+140.22%).
  • NVO quarterly short term debt is now -42.00% below its all-time high of $3.25 billion, reached on March 31, 2025.

Performance

NVO quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

NVO Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+89.7%+140.2%
3 y3 years-13.0%+966.0%
5 y5 years+722.4%+787.1%

NVO Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-13.0%+765.4%-42.0%+966.0%
5 y5-year-13.0%+765.4%-42.0%+966.0%
alltimeall time-13.0%>+9999.0%-42.0%>+9999.0%

NVO Short term debt History

DateAnnualQuarterly
Jun 2025
-
$1.88B(-42.0%)
Mar 2025
-
$3.25B(+78.2%)
Dec 2024
$1.82B(+89.7%)
$1.82B(+120.3%)
Sep 2024
-
$826.41M(+5.5%)
Jun 2024
-
$783.54M(-46.8%)
Mar 2024
-
$1.47B(+53.3%)
Dec 2023
$959.94M(+356.3%)
$959.94M(+2.2%)
Sep 2023
-
$938.92M(+1.9%)
Jun 2023
-
$921.49M(+405.1%)
Mar 2023
-
$182.45M(-13.3%)
Dec 2022
$210.39M(-89.9%)
$210.39M(-12.9%)
Sep 2022
-
$241.51M(+36.8%)
Jun 2022
-
$176.57M(-15.4%)
Mar 2022
-
$208.81M(-90.0%)
Dec 2021
$2.09B(+70.6%)
$2.09B(+894.4%)
Sep 2021
-
$210.41M(+1.4%)
Jun 2021
-
$207.48M(-80.8%)
Mar 2021
-
$1.08B(-12.1%)
Dec 2020
$1.23B(+453.7%)
$1.23B(+430.2%)
Sep 2020
-
$231.26M(+9.0%)
Jun 2020
-
$212.18M(+16.0%)
Mar 2020
-
$182.92M(-17.4%)
Dec 2019
$221.42M(+180.7%)
$221.42M(+7.1%)
Sep 2019
-
$206.76M(+8.0%)
Jun 2019
-
$191.49M(+14.3%)
Mar 2019
-
$167.55M(+112.4%)
Dec 2018
$78.89M(-71.1%)
$78.89M(+50.3%)
Sep 2018
-
$52.49M(+35.6%)
Jun 2018
-
$38.71M(+2.9%)
Mar 2018
-
$37.62M(-86.2%)
Dec 2017
$273.21M(+741.0%)
$273.21M(+561.5%)
Sep 2017
-
$41.30M(-84.0%)
Jun 2017
-
$258.18M(+192.8%)
Mar 2017
-
$88.17M(+171.4%)
Dec 2016
$32.48M(-79.2%)
$32.48M(-52.8%)
Sep 2016
-
$68.82M(+13.5%)
Jun 2016
-
$60.63M(-2.4%)
Mar 2016
-
$62.10M(-60.2%)
Dec 2015
$156.19M(+33.5%)
$156.19M(+65.7%)
Sep 2015
-
$94.27M(-14.2%)
Jun 2015
-
$109.93M(+28.7%)
Mar 2015
-
$85.39M(-27.0%)
Dec 2014
$117.00M(+194.6%)
$117.00M(+142.8%)
Sep 2014
-
$48.20M(-35.4%)
Jun 2014
-
$74.56M(-49.8%)
Mar 2014
-
$148.42M(+273.8%)
Dec 2013
$39.71M(-59.0%)
$39.71M(-67.4%)
Sep 2013
-
$121.79M(-6.7%)
Jun 2013
-
$130.53M(+10.5%)
Mar 2013
-
$118.16M(+22.0%)
Dec 2012
$96.84M
$96.84M(-4.6%)
Sep 2012
-
$101.47M(+53.2%)
Jun 2012
-
$66.23M(-3.4%)
DateAnnualQuarterly
Mar 2012
-
$68.56M(+10.6%)
Dec 2011
$321.90M(+202.6%)
$62.00M(-79.7%)
Sep 2011
-
$305.08M(+77.3%)
Jun 2011
-
$172.03M(-10.3%)
Mar 2011
-
$191.85M(+80.3%)
Dec 2010
$106.39M(+32.0%)
$106.39M(-42.0%)
Sep 2010
-
$183.38M(-65.9%)
Jun 2010
-
$537.38M(+185.4%)
Mar 2010
-
$188.30M(+133.6%)
Dec 2009
$80.60M(-67.6%)
$80.60M(+79.3%)
Sep 2009
-
$44.96M(-47.3%)
Jun 2009
-
$85.32M(-67.0%)
Mar 2009
-
$258.65M(+3.8%)
Dec 2008
$249.13M(+213.7%)
$249.13M(+64.4%)
Sep 2008
-
$151.55M(+54.9%)
Jun 2008
-
$97.81M(-25.6%)
Mar 2008
-
$131.53M(+65.6%)
Dec 2007
$79.41M(+32.8%)
$79.41M(+173.8%)
Sep 2007
-
$29.00M(+64.7%)
Jun 2007
-
$17.60M(-49.7%)
Mar 2007
-
$35.02M(-41.4%)
Dec 2006
$59.79M(-73.8%)
$59.79M(+16.5%)
Sep 2006
-
$51.30M(-8.2%)
Jun 2006
-
$55.88M(-70.7%)
Mar 2006
-
$190.87M(-16.4%)
Dec 2005
$228.36M(+146.5%)
$228.36M(+64.4%)
Sep 2005
-
$138.94M(+42.5%)
Jun 2005
-
$97.48M(+31.8%)
Mar 2005
-
$73.97M(-20.2%)
Dec 2004
$92.64M(-43.9%)
$92.64M(+27.3%)
Sep 2004
-
$72.77M(-11.4%)
Jun 2004
-
$82.17M(-37.3%)
Mar 2004
-
$131.06M(-20.6%)
Dec 2003
$165.17M(+107.3%)
$165.17M(+107.3%)
Dec 2002
$79.68M(-18.6%)
$79.68M(-18.6%)
Dec 2001
$97.84M(-5.3%)
$97.84M(-5.3%)
Dec 2000
$103.27M(-32.9%)
$103.27M(-23.3%)
Dec 1999
$153.95M(+6.2%)
$134.70M(-6.9%)
Dec 1998
$145.02M(-25.7%)
$144.65M(-26.4%)
Dec 1997
$195.11M(-14.7%)
$196.55M(-13.6%)
Dec 1996
$228.69M(-12.7%)
$227.43M(+74.0%)
Dec 1995
$261.82M(+10.8%)
$130.69M(-45.4%)
Dec 1994
$236.30M(+68.0%)
$239.22M(+68.7%)
Dec 1993
$140.62M(-11.7%)
$141.82M(-11.0%)
Dec 1992
$159.34M(-30.6%)
$159.33M(-30.6%)
Dec 1991
$229.49M(-22.9%)
$229.50M(-22.8%)
Dec 1990
$297.57M(+8.3%)
$297.39M(+8.7%)
Dec 1989
$274.66M(+50.3%)
$273.58M(+49.4%)
Dec 1988
$182.69M(+6.7%)
$183.09M(+6.9%)
Dec 1987
$171.23M(+1916.5%)
$171.23M(+1916.5%)
Dec 1986
$8.49M(+19.7%)
$8.49M(+19.7%)
Dec 1985
$7.10M(-91.8%)
$7.10M(-91.8%)
Dec 1984
$86.36M
$86.36M

FAQ

  • What is Novo Nordisk A/S annual short term debt?
  • What is the all time high annual short term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual short term debt year-on-year change?
  • What is Novo Nordisk A/S quarterly short term debt?
  • What is the all time high quarterly short term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly short term debt year-on-year change?

What is Novo Nordisk A/S annual short term debt?

The current annual short term debt of NVO is $1.82B

What is the all time high annual short term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual short term debt is $2.09B

What is Novo Nordisk A/S annual short term debt year-on-year change?

Over the past year, NVO annual short term debt has changed by +$860.91M (+89.68%)

What is Novo Nordisk A/S quarterly short term debt?

The current quarterly short term debt of NVO is $1.88B

What is the all time high quarterly short term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly short term debt is $3.25B

What is Novo Nordisk A/S quarterly short term debt year-on-year change?

Over the past year, NVO quarterly short term debt has changed by +$1.10B (+140.22%)
On this page